Risultati per: Position paper della French Headache Society sul trattamento dell'emicrania
Questo è quello che abbiamo trovato per te
Trattamento e prevenzione della cachessia neoplastica
2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache
Annals of Internal Medicine, Ahead of Print.
VA/DoD Clinical Practice Guideline for the Management of Headache
Annals of Internal Medicine, Ahead of Print.
Position paper della French Headache Society sul trattamento dell’emicrania
Emicrania, rimborsabile un nuovo farmaco orale preventivo
Studi clinici di fase 3 ne dimostrano l’efficacia
Effects of dim-evening lighting optimised for geographical orientation versus standard lighting on mental health: protocol paper for a quasiexperimental study in a psychiatric hospital
Introduction
Research has provided novel insights into how light stimulates circadian rhythms through specialised retinal ganglion cells to the suprachiasmatic nucleus. In addition, there has been a revolution in light-emitting diode (LED) technology, leading to tunable LED light sources and lighting systems, enabling 24-hour dynamic light scenarios with bright blue-enriched short wavelength light during the day and dim evening light, stimulating the circadian system. These dynamic LED lighting systems are now being implemented at hospitals without adequate understanding of how it may affect the health and well-being of patients and staff.
Methods and analysis
An optimised dynamic LED lighting scenario is investigated at a newly built psychiatric hospital in Copenhagen. In the 12 months baseline period, a standard lighting scenario with dynamic colour temperature and fixed light intensity is investigated. In the following 12-month intervention period, a new DEL scenario is investigated, having dynamic colour temperature as well as dynamic light intensity with a higher daytime and lower evening-time melanopic daylight equivalent illuminance. This setting is furthermore adjusted for geographical orientation to compensate for differences in sunlight access in wintertime. The study uses a quasiexperimental design comparing patients admitted in the two study periods. Prior to each of the study periods, daylight and the contribution from the LED-lighting scenarios was measured. Patient sociodemographic and mental health data will be retrieved retrospectively from electronic medical records and by questionnaires administered in the two periods, evaluating lighting, noise, sleep quality and quality of life. Primary outcome is the proportion of patients receiving pro re nata medications. Secondary outcomes are the length of stay, sleep onset latency, sleep quality and quality of life.
Ethics and dissemination
No ethical issues are expected. The results will be disseminated through peer-reviewed international journal, lectures, posters and interviews.
Trial registration number
NCT05868291.
Terapie farmacologiche per la gestione acuta dell’emicrania negli adulti
Infectious Diseases Society of America Releases New Guideline for Pemivibart
This Medical News story discusses new guidelines for the use of pemivibart, a monoclonal antibody marketed as Pemgarda, as preexposure prophylaxis against COVID-19 in immunocompromised individuals.
[News] European Society of Cardiology Research
The annual Congress for the European Society of Cardiology Research took place this summer in London, plunging researchers and clinicians into a heart racing weekend full of groundbreaking research, clinical trial updates, continued professional development and novel technologies. With over 31,000 attendees, 4,500 abstracts, 10 main lecture halls, multiple training sessions and Science Showcase boxes, the ESC had something for everyone. In addition to the standard industry stalls, there were onsite sensory breakout rooms, childcare facilities, patient advocate stalls, as well as a cardiovascular health check pit stop, complete with heart rate monitoring and blood testing for onsite metabolic profiling of lipids, cholesterol and HbA1c.
Nuova opzione di trattamento per la sclerosi multipla
Seeking a Better Paper Trail of Federal Research Funding
This work discusses initiatives designed to capture the value of public investment that will result in an accurate, comprehensive, and transparent paper trail of public funding.
La migliore soluzione per l’emicrania è rappresentata dai triptani
Emicrania, triptani low cost e più efficaci dei farmaci nuovi
Analisi su British Medical Journal,tuttavia sono sottoutilizzati
Fibrosi polmonare, Nerandomilast potenziale trattamento orale
Bene lo studio di fase III
Scambia, 'per il tumore di Bianca Balti ottime possibilità di trattamento'
‘In molti casi otteniamo la guarigione, ma la prevenzione è fondamentale’